Symbol="GALT"
AssetType="Common Stock"
Name="Galectin Therapeutics Inc"
Description="Galectin Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the research and development of therapies for fibrotic, cancerous and other diseases. The company is headquartered in Norcross, Georgia."
CIK="1133416"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="83415000"
EBITDA="None"
PERatio="None"
PEGRatio="0"
BookValue="-0.753"
DividendPerShare="0"
DividendYield="0"
EPS="-0.67"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.9"
ReturnOnEquityTTM="-37.28"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.67"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="11"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="207.7"
EVToRevenue="-"
EVToEBITDA="-2.412"
Beta="1.392"
num_52WeekHigh="2.47"
num_52WeekLow="1.02"
num_50DayMovingAverage="1.507"
num_200DayMovingAverage="1.541"
SharesOutstanding="59582000"
DividendDate="None"
ExDividendDate="None"
symbol="GALT"
open="1.39"
high="1.44"
low="1.37"
price="1.44"
volume="33682.00"
latest_trading_day="2023-08-10"
previous_close="1.40"
change="0.04"
change_percent="2.8571%"
aroon_positive_momentum_days="60"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="60"
Volume_recent_avg="55647"
Change_recent_avg="-0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.51"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="60"
Aroon_momentum_negative="40"
image_negative_thumbnail_id_1="153"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0023.jpeg"
image_negative_thumbnail_id_2="1165"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0199.jpeg"
image_neutral_thumbnail_id_1="552"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_neutral_thumbnail_id_2="577"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0022.jpeg"
image_positive_thumbnail_id_1="970"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0132.jpeg"
image_positive_thumbnail_id_2="993"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0155.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
